Journal of Leukocyte Biology Myeloid cells, immune suppression, tumor immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.0705377 on December 19, 2005

Published online before print December 19, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0705377v1
79/3/596    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walker, D. G.
Right arrow Articles by Boyes, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, D. G.
Right arrow Articles by Boyes, B. E.
(Journal of Leukocyte Biology. 2006;79:596-610.)
© 2006 by Society for Leukocyte Biology

Gene expression changes by amyloid ß peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes

Douglas G. Walker*,1, John Link{dagger}, Lih-Fen Lue*, Jessica E. Dalsing-Hernandez* and Barry E. Boyes{dagger}

* Laboratory of Neuroinflammation, Sun Health Research Institute, Sun City, Arizona; and
{dagger} Agilent Technologies, Wilmington, Delaware

1 Correspondence: Sun Health Research Institute, 10515 West Santa Fe Drive, Sun City, AZ 85351. E-mail: douglas.walker{at}sunhealth.org

A central feature of the inflammatory pathology in Alzheimer’s disease is activated microglia clustered around aggregated amyloid ß (Aß) peptide-containing plaques. In vitro-cultured microglia can be activated to an inflammatory state by aggregated Aß with the induction of a range of different neurotoxic factors and provide a model system for studying microglia Aß interactions. Gene expression responses of human postmortem brain-derived microglia to aggregated Aß were measured using whole genome microarrays to address the hypothesis that Aß interactions with human microglia primarily induce proinflammatory genes and not activation of genes involved in Aß phagocytosis and removal. The results demonstrated that Aß activation of microglia induced a large alteration in gene transcription including activation of many proinflammatory cytokines and chemokines, most notably, interleukin (IL)-1ß, IL-8, and matrix metalloproteinases (MMP), including MMP1, MMP3, MMP9, MMP10, and MMP12. All of these genes could amplify ongoing inflammation, resulting in further neuronal loss. Changes in expression of receptors associated with Aß phagocytosis did not match the changes in proinflammatory gene expression. Time-course gene expression profiling, along with real-time polymerase chain reaction validation of expression changes, demonstrated an acute phase of gene induction for many proinflammatory genes but also chronic activation for many other potentially toxic products. These chronically activated genes included indoleamine 2,3-dioxygenase and kynureninase, which are involved in formation of the neurotoxin quinolinic acid, and S100A8, a potential proinflammatory chemokine. These studies show that activation of microglia by Aß induces multiple genes that could be involved in inflammatory responses contributing to neurodegenerative processes.

Key Words: calgranulin • cytokine • metalloproteinase




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Jana, C. A. Palencia, and K. Pahan
Fibrillar Amyloid-{beta} Peptides Activate Microglia via TLR2: Implications for Alzheimer's Disease
J. Immunol., November 15, 2008; 181(10): 7254 - 7262.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Afkhami-Goli, F. Noorbakhsh, A. J. Keller, N. Vergnolle, D. Westaway, J. H. Jhamandas, P. Andrade-Gordon, M. D. Hollenberg, H. Arab, R. H. Dyck, et al.
Proteinase-Activated Receptor-2 Exerts Protective and Pathogenic Cell Type-Specific Effects in Alzheimer's Disease
J. Immunol., October 15, 2007; 179(8): 5493 - 5503.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Fiala, P. T. Liu, A. Espinosa-Jeffrey, M. J. Rosenthal, G. Bernard, J. M. Ringman, J. Sayre, L. Zhang, J. Zaghi, S. Dejbakhsh, et al.
Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin
PNAS, July 31, 2007; 104(31): 12849 - 12854.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Leukocyte Biology.